Partillion Bioscience Corporation
PrivateLast Round
Seed
Sep 26, 2023
Total Funding Raised
$8.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Partillion Bioscience Corporation operates in Healthcare & Life Sciences and is based in Los Angeles, California. Its latest recorded funding round was a Seed round in September 2023.
Partillion Bioscience Corporation is a biotechnology company that provides a nanovial platform for the rapid compartmentalization and analysis of millions of single cells to probe biological functions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Partillion Bioscience Corporation Comparables
Compare Partillion Bioscience Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellChorus | 81% | |
| LiveDrop SA | 80% | |
| Sampling Human, Inc. | 79% |
For institutional investors. Book with your work email.
Partillion Bioscience Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 26, 2023 | ||||
| Grant | Sep 13, 2023 | ||||
| Grant | Sep 6, 2023 | ||||
| Grant | Sep 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Partillion Bioscience Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Vertical Venture Partners | Seed |
| ND Capital | Seed |
| General Inception | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 31% MoM.
- Apr 21, 2026
Attended the 2026 Cell-Cell Symposium and introduced new progress in cell interaction studies.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withSep 9, 2026
Partillion Bioscience Corporation partners with Sony Biotechnology Inc. through a distribution partnership launched in 2024.
- receives_financingSep 9, 2026
Partillion Bioscience Corporation received financing of $2.1M in NIH SBIR grant on Sep 9th '26.
- attends_eventSep 2, 2026
Partillion Bioscience Corporation attends the 49th Annual Course in Cytometry in California in Aug '26 and trains researchers to run Nanovial-based functional assays on two commercial cell sorting platforms.
For institutional investors. Book with your work email.
Partillion Bioscience Corporation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Partillion Bioscience Corporation's valuation, stock price, and market status.
Is Partillion Bioscience Corporation a public or private company?
Partillion Bioscience Corporation is a private company.
What is the current stock price of Partillion Bioscience Corporation?
Partillion Bioscience Corporation is a private company, so its shares have no public market price. Caplight tracks Partillion Bioscience Corporation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Partillion Bioscience Corporation worth (valuation)?
Valuation information for Partillion Bioscience Corporation is not publicly available.
Can I buy Partillion Bioscience Corporation stock?
Partillion Bioscience Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Partillion Bioscience Corporation's last funding round?
Partillion Bioscience Corporation's most recent funding round was Seed on September 26, 2023.
Who are the main investors in Partillion Bioscience Corporation?
Key investors in Partillion Bioscience Corporation include ND Capital.
Will Partillion Bioscience Corporation IPO soon?
No public IPO plans have been announced for Partillion Bioscience Corporation.
How can I track Partillion Bioscience Corporation secondary market activity?
Caplight tracks bids, offers, and trades in Partillion Bioscience Corporation's shares on secondary markets.